Atoosa Rabiee
LightNews LightNews
banner
atoosarabiee.bsky.social
Atoosa Rabiee
@atoosarabiee.bsky.social
620 followers 310 following 110 posts
Transplant hepatologist
Chief of Transplant|Director of Hepatology @DCVAMC @HopkinsMedicine@UMiamiHealth
#liversky|#livercancer|#portalHT|#MEDed
Posts Replies Media Videos
atoosarabiee.bsky.social
Next gen hepatology

Session by communication and technology committee

All brilliant speakers!

Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
November 10, 2025 at 4:04 PM
atoosarabiee.bsky.social
Best practices of management of obesity in liver transplant

FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼

Her beautiful graph won the cover photo 👌🏼

#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
November 9, 2025 at 4:09 PM
atoosarabiee.bsky.social
Recompensation take home points

⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening

@anahitarabiee.bsky.social
#liversky
#TLM25
November 8, 2025 at 1:50 PM
atoosarabiee.bsky.social
VA hepatitis C team winning the distinguished advocacy award.
Truly well deserved 👏🏼
#liversky
#TLM25
November 8, 2025 at 1:47 AM
atoosarabiee.bsky.social
Kicking off the meeting with some of my favorite people
#TLM25 #liversky
November 7, 2025 at 11:57 PM
atoosarabiee.bsky.social
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

If you take care of patients with #HCC, do not miss this new update from BCLC

#liversky

@easlnews.bsky.social

www.journal-of-hepatology.eu/article/S016....
October 27, 2025 at 5:21 PM
atoosarabiee.bsky.social
In anticipation of registration for @bavenocoop.bsky.social VIII

Do not miss this new publication on
refining Baveno VII criteria for CSPH
individual-patient data meta-analysis

#liversky
pubmed.ncbi.nlm.nih.gov/41138818/
@easlnews.bsky.social
October 27, 2025 at 5:18 PM
atoosarabiee.bsky.social
Once bleeding is controlled with banding:

Can duration of octreotide infusion be shortened?

In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality
#liversky
@amcollegegastro.bsky.social

pubmed.ncbi.nlm.nih.gov/41090987/
October 27, 2025 at 5:16 PM
atoosarabiee.bsky.social
📌A dual burden

HCC risk is increased in MetALD compared to MASLD

In a large cohort of VA patients, HCC risk
MASLD>>MetALD>>ALD

#liversky
@easlnews.bsky.social

www.sciencedirect.com/science/arti...
October 27, 2025 at 5:12 PM
atoosarabiee.bsky.social
📌 AGA clinical practice update on ascites and hyponatremia

@amergastroassn.bsky.social

#liversky

www.gastrojournal.org/article/S001...
October 27, 2025 at 4:58 PM
atoosarabiee.bsky.social
Changes in trend and comparison of outcomes of TACE vs TARE as bridge therapy for patients with HCC on LT list

#liversky

@aasldnews.bsky.social
October 14, 2025 at 1:45 AM
atoosarabiee.bsky.social
Important study on use of ICI post-transplant

Only one rejection!

#liversky
@aasldnews.bsky.social

journals.lww.com/lt/abstract/...
October 14, 2025 at 1:44 AM
atoosarabiee.bsky.social
Ever wonder what happens to your liver after binge drinking?
This study showed
📌increased hepatic fat fraction by 2.5-fold in healthy adults
📌increased liver stiffness
📌increased plasma triglycerides
Good news:
All normalized with 10 days of abstinence
#liversky
www.jhep-reports.eu/cms/10.1016/...
October 14, 2025 at 1:40 AM
atoosarabiee.bsky.social
Optimal sequencing post immunotherapy for HCC as first line

A good overview

#liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...
October 14, 2025 at 1:37 AM
atoosarabiee.bsky.social
Comprehensive review on evolution of immunotherapy for HCC

#liversky
#HCC
@aasldnews.bsky.social
journals.lww.com/hep/abstract...
October 14, 2025 at 1:18 AM
atoosarabiee.bsky.social
A great review on a not so common liver disease

"Sarcoid in liver"

#liversky
@aasldnews.bsky.social
journals.lww.com/hep/abstract...
October 14, 2025 at 1:16 AM
atoosarabiee.bsky.social
HES V2.0 biomarker panel (AFP, AFP-L3, and DCP, their gradient, if available), ALT, platelets, etiology showed higher sensitivity than GALAD at 12 months for HCC diagnosis

#liversky
@jhepatology.bsky.social
www.journal-of-hepatology.eu/article/S016...
October 14, 2025 at 12:21 AM
atoosarabiee.bsky.social
If you are in the field of liver transplant, do not miss the 1st successful porcine liver xenotransplantation to a living recipient

Postoperative xTMA -> significant challenge to long-term success
#Liversky
@jhepatology.bsky.social
www.journal-of-hepatology.eu/article/S016...
October 13, 2025 at 11:50 PM
atoosarabiee.bsky.social
Beautiful study looking at effects of early PoPH on mortality in patients with cirrhosis

#liversky
@jhepatology.bsky.social
www.journal-of-hepatology.eu/article/S016...
October 13, 2025 at 11:46 PM
atoosarabiee.bsky.social
Great review of reproductive health in the liver transplant recipient by Dr Sarkar et al

journals.lww.com/lt/abstract/...

#liversky
September 29, 2025 at 12:12 AM
atoosarabiee.bsky.social
Multinational real-world data supports lenvatinib as preferred second-line option in HCC treatment
👇🏼👇🏼👇🏼

www.jhep-reports.eu/article/S258...

#liversky
@easlnews.bsky.social
September 29, 2025 at 12:09 AM
atoosarabiee.bsky.social
If you are interested in portal hypertension and like to hear from all disciplines involved, this is the conference for you 👇🏼

Thank you for the invitation and the opportunity to review HRS-AKI and ascites management.

#liversky
@portal360mtg.bsky.social
@bavenocoop.bsky.social
September 26, 2025 at 4:10 PM
atoosarabiee.bsky.social
In this study on reactivation of hepatitis B in patients with HCC

✅ Overall risk of HBV reactivation is low
✅ Risk is no affected by the choice of TKI or different types of ICI

#Liversky

onlinelibrary.wiley.com/doi/full/10....
September 16, 2025 at 1:18 AM
atoosarabiee.bsky.social
AlcHepNet consortium puts the focus on early intervention

712 AH patients
Composite event 64%
Liver transplant 12%
Mortality in severe AH
17% (30d), 26% (90d), 30% (180d)
Higher mortality:
High MELD score
Low MAP
Leukocytosis

#liversky

@aasldnews.bsky.social

journals.lww.com/hep/abstract...
September 16, 2025 at 1:00 AM
atoosarabiee.bsky.social
Save and keep it handy for when you are asked to “clear” patients with cirrhosis.

Or as I prefer to say it “have a risk, benefit discussion before surgical procedures”

There is also a visual highlight 🤩

journals.lww.com/ajg/fulltext...

@amcollegegastro.bsky.social

#liversky
September 10, 2025 at 2:38 PM